Literature DB >> 388134

A double blind placebo controlled crossover study of prostacyclin in man.

G A FitzGerald, L A Friedman, I Miyamori, J O'Grady, P J Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 388134     DOI： 10.1016/0024-3205(79)90507-1

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  24 in total

1.  Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.

Authors:  G A FitzGerald; A R Brash; J A Oates; A K Pedersen
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

2.  The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.

Authors:  G Allan; M J Follenfant; P Lidbury; P L Oliver; B J Whittle
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

3.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

4.  The effect of prostacyclin on cerebral vasospasm. An experimental study.

Authors:  L Quintana; R Konda; Y Ishibashi; T Yoshimoto; J Suzuki
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

5.  Release of prostacyclin from the human pulmonary vascular bed in response to cholinergic stimulation.

Authors:  R Brandt; A Dembińska-Kieć; R Korbut; R J Gryglewski; J Nowak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

6.  The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.

Authors:  S Hassan; H Pickles; A Fish; C Burke; S Warrington; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

7.  A lack of effect of captopril on platelet aggregation in patients with congestive heart failure.

Authors:  I F Gow; A D Flapan; M Morris; E Davies; B C Williams; P L Padfield; T R Shaw; C R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.

Authors:  J O'Grady; A Hedges; B J Whittle; L A Al-Sinawi; Q A Mekki; C Burke; S G Moody; M J Moti; S Hassan
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

9.  Indomethacin does not attenuate the effects of hydralazine in normal subjects.

Authors:  S H Jackson; H Pickles
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Prostacyclin influences the pressure reactivity in patients with severe traumatic brain injury treated with an ICP-targeted therapy.

Authors:  Lars-Owe D Koskinen; Anders Eklund; Nina Sundström; Magnus Olivecrona
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.